LUCD ▲ +2.4% - Lucid Diagnostics Inc. $LUCD LUCD PAVM - Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways Lucid Diagnostics rose 2.4% following the company's advancement of multiple payment, billing, and coding pathways for its EsoGuard and EsoCheck diagnostic products, a development that could reduce barriers to patient access and reimbursement for the company's esophageal cancer screening tests. 22-SEP-2026 07:55 AM ET